PillCam ESO versus esophagogastroduodenoscopy in esophageal variceal screening: A decision analysis

Journal of Clinical Gastroenterology

Volumn 43, Issue 10, 2009, Pages 975-981

  White, Christopher M ^a,b   Kilgore, Meredith L ^b  

^a Division of Gastroenterology and Hepatology

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Capsule endoscopy; Cost analysis; Esophageal varices; Hepatic cirrhosis

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; NADOLOL;

ARTICLE; CAMERA; CAPSULE ENDOSCOPE; CAPSULE ENDOSCOPY; COST EFFECTIVENESS ANALYSIS; ESOPHAGOGASTRODUODENOSCOPY; ESOPHAGUS VARICES; ESOPHAGUS VARICES BLEEDING; GOLD STANDARD; HEALTH CARE COST; HUMAN; INTERMETHOD COMPARISON; LIVER CIRRHOSIS; PORTAL HYPERTENSION; PRIORITY JOURNAL; PROBABILITY; SCREENING TEST; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; DECISION SUPPORT SYSTEM; DIGESTIVE TRACT ENDOSCOPY; ECONOMICS; MASS SCREENING; METHODOLOGY; MIDDLE AGED;

CAPSULE ENDOSCOPY; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; ENDOSCOPY, DIGESTIVE SYSTEM; ESOPHAGEAL AND GASTRIC VARICES; HUMANS; LIVER CIRRHOSIS; MARKOV CHAINS; MASS SCREENING; MIDDLE AGED;

EID: 74949083536     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3181a7ed09     Document Type: Article

References (76)

1. Garcia-Tsao G, Sanyal AJ, Grace ND, et al. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology. 2007;46:922-938. (Pubitemid 47436138)
2. Sharara AI, Rockey DC. Gastroesophageal variceal hemorrhage. N Engl J Med. 2001;345:669-681.
3. Spiegel BM, Esrailian E, Eisen G. The budget impact of endoscopic screening for esophageal varices in cirrhosis. Gastrointest Endosc. 2007;66:679-692.
4. D'Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology. 1995;22: 332-354.
5. D'Amico G, Pagliaro L, Bosch J. Pharmacological treatment of portal hypertension: an evidence-based approach. Semin Liver Dis. 1999;19:475-505. (Pubitemid 30032646)
6. Saab S, DeRosa V, Nieto J, et al. Costs and clinical outcomes of primary prophylaxis of variceal bleeding in patients with hepatic cirrhosis: a decision analytic model. Am J Gastroenterol. 2003;98:763-770.
7. De Franchis R, Dell'Era A. Non-invasive diagnosis of cirrhosis and the natural history of its complications. Best Pract Res Clin Gastroenterol. 2007;21:3-18.
8. Arguedas MR, Heudebert GR, Eloubeidi MA, et al. Costeffectiveness of screening, surveillance, and primary prophylaxis strategies for esophageal varices. Am J Gastroenterol. 2002;97:2441-2452.
9. Albillos A. Preventing first variceal hemorrhage in cirrhosis. J Clin Gastroenterol. 2007;41(10 suppl 3):S305-S311.
10. Triantos CK, Burroughs AK. Prevention of the development of varices and first portal hypertensive bleeding episode. Best Pract Res Clin Gastroenterol. 2007;21:31-42.
11. Spiegel BM, Targownik L, Dulai GS, et al. Endoscopic screening for esophageal varices in cirrhosis: is it ever cost effective. Hepatology. 2003;37:366-377.
12. Kovalak M, Lake J, Mattek N, et al. Endoscopic screening for varices in cirrhotic patients: data from a national endoscopic database. Gastrointest Endosc. 2007;65:82-88.
13. Burroughs AK. The natural history of varices. J Hepatol. 1993; 17(suppl 2):S10-S13.
14. Jensen DM. Endoscopic screening for varices in cirrhosis: findings, implications, and outcomes. Gastroenterology. 2002; 122:1620-1630.
15. Schepis F, Camma C, Niceforo D, et al. Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection? Hepatology. 2001;33:333-338.
16. De Franchis R, Dell'era A, Primignani M. Diagnosis and monitoring of portal hypertension. Dig Liver Dis. 2008;40: 312-317.
17. Imperiale TF, Klein RW, Chalasani N. Cost-effectiveness analysis of variceal ligation versus beta-blockers for primary prevention of variceal bleeding. Hepatology. 2007;45:870-878.
18. Bernard B, Lebrec D, Mathurin P, et al. Beta-adrenergic antagonists in the prevention of gastrointestinal rebleeding in patients with cirrhosis: a meta-analysis. Hepatology. 1997;25: 63-70. (Pubitemid 27014986)
19. Kravetz D. Prevention of recurrent esophageal variceal hemorrhage: review and current recommendations. J Clin Gastroenterol. 2007;41(10 suppl 3):S318-S322.
20. Lo GH, Chen WC, Chen MH, et al. Endoscopic ligation versus nadolol in the prevention of first variceal bleeding in patients with cirrhosis. Gastrointest Endosc. 2004;59:333-338.
21. Khuroo MS, Khuroo NS, Farahat KL, et al. Meta-analysis: endoscopic variceal ligation for primary prophylaxis of oesophageal variceal bleeding. Aliment Pharmacol Ther. 2005; 21:347-361.
22. Gluud LL, Klingenberg S, Nikolova D, et al. Banding ligation versus beta-blockers as primary prophylaxis in esophageal varices: systematic review of randomized trials. Am J Gastroenterol. 2007;102:2842-2848.
23. Tripathi D, Graham C, Hayes PC. Variceal band ligation versus beta-blockers for primary prevention of variceal bleeding: a meta-analysis. Eur J Gastroenterol Hepatol. 2007; 19:835-845.
24. Schepke M, Kleber G, Nurnberg D, et al. Ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology. 2004;40:65-72.
25. Imperiale TF, Chalasani N. A meta-analysis of endoscopic variceal ligation for primary prophylaxis of esophageal variceal bleeding. Hepatology. 2001;33:802-807.
26. Lay CS, Tsai YT, Teg CY, et al. Endoscopic variceal ligation in prophylaxis of first variceal bleeding in cirrhotic patients with high-risk esophageal varices. Hepatology. 1997;25: 1346-1350.
27. Sarin SK, Lamba GS, Kumar M, et al. Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding. N Engl J Med. 1999;340:988-993.
28. De Franchis R. Updating consensus in portal hypertension: report of the Baveno III consensus workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol. 2000;33:846-852.
29. Eisen G, Baron TH, Dominitz J. American Society for Gastrointestinal Endoscopy. Complications of upper GI endoscopy. Gastrointest Endosc. 2002;55:784-793.
30. Eisen GM. PillCam ESO: a primer. Tech Gastrointest Endosc. 2006;8:154-159.
31. Eisen GM, Eliakim R, Zaman A, et al. The accuracy of PillCam ESO capsule endoscopy versus conventional upper endoscopy for the diagnosis of esophageal varices: a prospective three-center pilot study. Endoscopy. 2006;38:31-35.
32. Lapalus MG, Dumortier J, Fumex F, et al. Esophageal capsule endoscopy versus esophagogastroduodenoscopy for evaluating portal hypertension: a prospective comparative study of performance and tolerance. Endoscopy. 2006;38:36-41.
33. Groce JR, Raju GS, Sood GK, et al. A prospective single blinded comparative trial of capsule esophagoscopy versus traditional EGD for variceal screening. Gastroenterology. 2007;132 (suppl 2):A802.
34. Pena LR, Cox T, Koch AG, et al. Study comparing oesophageal capsule endoscopy versus EGD in the detection of varices. Dig Liver Dis. 2008;40:216-223.
35. De Franchis R, Eisen GM, Laine L, et al. Esophageal capsule endoscopy for screening and surveillance of esophageal varices in patients with portal hypertension. Hepatology. 2008;47: 1595-1603.
36. Chalasani N, Imperiale TF, Ismail A, et al. Predictors of large esophageal varices in patients with cirrhosis. Am J Gastroenterol. 1999;94:3285-3291.
37. Zaman A, Hapke R, Flora K, et al. Factors predicting the presence of esophageal or gastric varices in patients with advanced liver disease. Am J Gastroenterol. 1999;94:3292-3296.
38. Merli M, Nicolini G, Angeloni S, et al. Incidence and natural history of small esophageal varices in cirrhotic patients. J Hepatol. 2003;38:266-272.
39. Lo GH, Lai KH, Cheng JS, et al. Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: a prospective, randomized trial. Hepatology. 2000;32:461-465.
40. De la Pena J, Brullet E, Sanchez-Hernandez E, et al. Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding: a multicenter trial. Hepatology. 2005;41: 572-578.
41. Sangiovanni A, Prati GM, Fasani P, et al. The natural history of compensated cirrhosis due to hepatitis C virus: a 17-year cohort study of 214 patients. Hepatology. 2006;43:1303-1310.
42. Fattovich G, Giustina G, Degos F, et al. Morbidity and mortality in compensated cirrhosis type c: a retrospective follow-up study of 384 patients. Gastroenterology. 1997;112: 463-472.
43. Chu CM, Liaw YF. Hepatitis B virus-related cirrhosis: natural history and treatment. Semin Liver Dis. 2006;26:142-152.
44. D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44:217-231.
45. Naveau S, Perlemuter G, Balian A. Epidemiology and natural history of cirrhosis. Rev Prat. 2005;55:1527-1532.
46. Planas R, Balleste B, Alvarez MA, et al. Natural history of decompensated hepatitis c virus-related cirrhosis. A study of 200 patients. J Hepatol. 2004;40:823-830.
47. Chan MF. Complications of upper gastrointestinal endoscopy. Gastrointest Endosc Clin N Am. 1996;6:287-303.
48. Kavic SM, Basson MD. Complications of endoscopy. Am J Surg. 2001;181:319-332.
49. Brinster CJ, Singhal S, Lee L, et al. Evolving options in the management of esophageal perforation. Ann Thorac Surg. 2004;77:1475-1483.
50. ASGE. Complications of upper GI endoscopy. Gastrointest Endosc. 2002;55:784-793.
51. McLernon DJ, Donnan PT, Crozier A, et al. A study of the safety of current gastrointestinal endoscopy (EGD). Endoscopy. 2007;39:692-700.
52. Sharma VK, Nguyen CC, Crowell MD, et al. A national study of cardiopulmonary unplanned events after GI endoscopy. Gastrointest Endosc. 2007;66:27-34.
53. Quine MA, Bell GD, McCloy RF, et al. Prospective audit of perforation rates following upper gastrointestinal endoscopy in two regions of England. Br J Surg. 1995;82:530-533.
54. Sawyer R, Phillips C, Vakil N. Short- and long-term outcome of esophageal perforation. Gastrointest Endosc. 1995;41:130-134.
55. Bufkin BL, Miller JI, Mansour KA. Esophageal perforation: emphasis on management. Ann Thorac Surg. 1996;61:1447-1452.
56. Gupta NM, Kaman L. Personal management of 57 consecutive patients with esophageal perforation. Am J Surg. 2004;187: 58-63.
57. Vogel SB, Rout WR, Martin TD, et al. Esophageal perforation in adults: aggressive, conservative treatment lowers morbidity and mortality. Ann Surg. 2005;241:1016-1021.
58. Sung SW, Park JJ, Kim YT, et al. Surgery in thoracic esophageal perforation: primary repair is feasible. Dis Esophagus. 2002;15:204-209.
59. Eroglu A, Can Kurkcuogu I, Karaoganogu N, et al. Esophageal perforation: the importance of early diagnosis and primary repair. Dis Esophagus. 2004;17:91-94.
60. Okten I, Cangir AK, Ozdemir N, et al. Management of esophageal perforation. Surg Today. 2001;31:36-39.
61. Eliakim R, Yassin K, Shlomi I, et al. A novel diagnostic tool for detecting oesophageal pathology: the PillCam oesophageal video capsule. Aliment Pharmacol Ther. 2004;20:1083-1089.
62. Eliakim R, Sharma VK, Yassin K, et al. A prospective study of the diagnostic accuracy of PillCam ESO esophageal capsule endoscopy versus conventional upper endoscopy in patients with chronic gastroesophageal reflux diseases. J Clin Gastroenterol. 2005;39:572-578.
63. Sanchez-Yague A, Caunedo-Alvarez A, Garcia-Montes JM, et al. Esophageal capsule endoscopy in patients refusing conventional endoscopy for the study of suspected esophageal pathology. Eur J Gastroenterol Hepatol. 2006;18:977-983.
64. Delvaux M, Papanikolaou IS, Fassler I, et al. Esophageal capsule endoscopy in patients with suspected esophageal disease: double blinded comparison with esophagogastroduodenoscopy and assessment of interobserver variability. Endoscopy. 2008;40:16-22.
65. Lin OS, Schembre DB, Mergener K, et al. Blinded comparison of esophageal capsule endoscopy versus conventional endoscopy for a diagnosis of Barrett's esophagus in patients with chronic gastroesophageal reflux. Gastrointest Endosc. 2007;65: 577-583.
66. Sharma P, Wani S, Rastogi A, et al. The diagnostic accuracy of esophageal capsule endoscopy in patients with gastroesophageal reflux disease and Barrett's esophagus: a blinded, prospective study. Am J Gastroenterol. 2008;103:525-532.
67. Galmiche JP, Sacher-Huvelin S, Coron E, et al. Screening for esophagitis and Barrett's esophagus with wireless esophageal capsule endoscopy: a multicenter prospective trial in patients with reflux symptoms. Am J Gastroenterol. 2008;103:538-545.
68. Sarin SK, Guptan RK, Jain AK, et al. A randomized controlled trial of endoscopic variceal band ligation for primary prophylaxis of variceal bleeding. Eur J Gastroenterol Hepatol. 1996;8:337-342.
69. www.drugstore.com. Accessed April 28, 2008.
70. Gerson LB, Lin O. Cost-benefit analysis of capsule endoscopy compared to standard upper endoscopy for the detection of Barrett's esophagus. Gastrointest Endosc. 2006;63:AB142.
71. Kilgore ML. Effects of trial design on participation and costs in clinical trials, with an examination of cost analysis methods and data sources. PhD Dissertation Pardee RAND Graduate School. 2004;81-104.
72. United States Department of Labor Bureau of Labor Statistics. Consumer price index inflation calculator. Available at: http://data.bls.gov/cgi-bin/ cpicalc.pl. Accessed on: April 25, 2008.
73. Schnoll-Sussman F, Kulkarni K. Risks of capsule endoscopy. Tech Gastrointest Endosc. 2008;10:25-30.
74. Cheon JH, Kim YS, Lee IS, et al. Can we predict spontaneous capsule passage after retention? A nationwide study to evaluate the incidence and clinical outcomes of capsule retention. Endoscopy. 2007;39:1046-1052.
75. Pennazio M. Capsule endoscopy: where are we after 6 years of clinical use? Dig Liver Dis. 2006;38:867-878.
76. Rondonotti E, Herrerias JM, Pennazio M, et al. Complications, limitations, and failures of capsule endoscopy: a review of 733 cases. Gastrointest Endosc. 2005;62:712-716.